# Tempest Therapeutics, Inc.: Form SCHEDULE 13D, filed Feb 10, 2026

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: SCHEDULE 13D
- Filed: 2026-02-10
- Accepted by EDGAR: Feb 10, 2026, 17:15 ET
- Period: not reported
- Accession: 0001931356-26-000009
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000193135626000009/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000193135626000009/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000193135626000009/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001931356-26-000009. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
